• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chemokines in tumor angiogenesis and metastasis.趋化因子在肿瘤血管生成和转移中的作用
Cancer Metastasis Rev. 2007 Dec;26(3-4):453-67. doi: 10.1007/s10555-007-9068-9.
2
Chemokines and their role in tumor growth and metastasis.趋化因子及其在肿瘤生长和转移中的作用。
J Immunol Methods. 1998 Nov 1;220(1-2):1-17. doi: 10.1016/s0022-1759(98)00128-8.
3
Chemokines in tumor progression and metastasis.趋化因子在肿瘤进展和转移中的作用
Cancer Sci. 2005 Jun;96(6):317-22. doi: 10.1111/j.1349-7006.2005.00059.x.
4
Chemokines.趋化因子
Recent Results Cancer Res. 2010;180:35-50. doi: 10.1007/978-3-540-78281-0_4.
5
The role of chemokines and their receptors in angiogenesis.趋化因子及其受体在血管生成中的作用。
Cell Mol Life Sci. 2011 Sep;68(17):2811-30. doi: 10.1007/s00018-011-0677-7. Epub 2011 Apr 9.
6
The chemokine system -- a major regulator of angiogenesis in health and disease.趋化因子系统——健康与疾病中血管生成的主要调节因子。
APMIS. 2004 Jul-Aug;112(7-8):481-95. doi: 10.1111/j.1600-0463.2004.apm11207-0808.x.
7
Role of chemokines in tumor growth.趋化因子在肿瘤生长中的作用。
Cancer Lett. 2007 Oct 28;256(2):137-65. doi: 10.1016/j.canlet.2007.05.013. Epub 2007 Jul 12.
8
The role of CXC chemokines in the regulation of tumor angiogenesis.CXC趋化因子在肿瘤血管生成调节中的作用。
Cancer Invest. 2001;19(7):732-8. doi: 10.1081/cnv-100106148.
9
Chemokines: novel targets for breast cancer metastasis.趋化因子:乳腺癌转移的新靶点。
Cancer Metastasis Rev. 2007 Dec;26(3-4):401-20. doi: 10.1007/s10555-007-9073-z.
10
Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization.趋化因子及其受体:肿瘤转移的协调者。
Int J Mol Sci. 2018 Dec 27;20(1):96. doi: 10.3390/ijms20010096.

引用本文的文献

1
Distinctive roles of aquaporins and novel therapeutic opportunities against cancer.水通道蛋白的独特作用及抗癌新治疗机遇
RSC Med Chem. 2024 Dec 17. doi: 10.1039/d4md00786g.
2
The paradoxical role of cytokines and chemokines at the tumor microenvironment: a comprehensive review.细胞因子和趋化因子在肿瘤微环境中的矛盾作用:全面综述。
Eur J Med Res. 2024 Feb 15;29(1):124. doi: 10.1186/s40001-024-01711-z.
3
Functional Analysis of Membrane-Associated Scaffolding Tight Junction (TJ) Proteins in Tumorigenic Characteristics of B16-F10 Mouse Melanoma Cells.膜相关支架紧密连接 (TJ) 蛋白在 B16-F10 小鼠黑色素瘤细胞致瘤特性中的功能分析。
Int J Mol Sci. 2024 Jan 9;25(2):833. doi: 10.3390/ijms25020833.
4
Integrated multiplex network based approach reveled CC and CXC chemokines associated key biomarkers in colon adenocarcinoma patients.基于整合多重网络的方法揭示了结肠腺癌患者中CC和CXC趋化因子相关的关键生物标志物。
Am J Cancer Res. 2023 Nov 15;13(11):5531-5548. eCollection 2023.
5
Investigating novel biomarkers in uterine corpus endometrial carcinoma: in silico analysis and clinical specimens validation via RT-qPCR and immunohistochemistry.子宫体子宫内膜癌新型生物标志物的研究:通过RT-qPCR和免疫组织化学进行计算机分析及临床标本验证
Am J Cancer Res. 2023 Sep 15;13(9):4376-4400. eCollection 2023.
6
Role of the tumor microenvironment in the lymphatic metastasis of cervical cancer (Review).肿瘤微环境在宫颈癌淋巴转移中的作用(综述)
Exp Ther Med. 2023 Sep 1;26(4):486. doi: 10.3892/etm.2023.12185. eCollection 2023 Oct.
7
Modifiable Pancreatic Ductal Adenocarcinoma (PDAC) Risk Factors.可改变的胰腺导管腺癌(PDAC)风险因素。
J Clin Med. 2023 Jun 27;12(13):4318. doi: 10.3390/jcm12134318.
8
Regulation of Cancer Stem Cells and Epithelial-Mesenchymal Transition by CTNNAL1 in Lung Cancer and Glioblastoma.CTNNAL1对肺癌和胶质母细胞瘤中癌症干细胞及上皮-间质转化的调控
Biomedicines. 2023 May 17;11(5):1462. doi: 10.3390/biomedicines11051462.
9
Involvement of CXCL12/CXCR4 axis in colorectal cancer: a mini-review.CXCL12/CXCR4 轴在结直肠癌中的作用:小型综述。
Mol Biol Rep. 2023 Jul;50(7):6233-6239. doi: 10.1007/s11033-023-08479-1. Epub 2023 May 23.
10
The influence of chirality on the behavior of oligonucleotides inside cells: revealing the potent cytotoxicity of G-rich l-RNA.手性对细胞内寡核苷酸行为的影响:揭示富含鸟嘌呤的 l - RNA 的强细胞毒性
Chem Sci. 2022 Dec 30;14(5):1145-1154. doi: 10.1039/d2sc05511b. eCollection 2023 Feb 1.

本文引用的文献

1
Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.CXCR4、VEGF和MMP-9的重组预测人类乳腺癌中的淋巴结转移。
Cancer Lett. 2007 Aug 8;253(1):34-42. doi: 10.1016/j.canlet.2007.01.005. Epub 2007 Feb 16.
2
Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes.趋化因子受体CXCR3促进结肠癌向淋巴结转移。
Oncogene. 2007 Jul 12;26(32):4679-88. doi: 10.1038/sj.onc.1210267. Epub 2007 Feb 5.
3
CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases.癌症骨转移中的CCL2(单核细胞趋化蛋白-1)
Cancer Metastasis Rev. 2006 Dec;25(4):611-9. doi: 10.1007/s10555-006-9027-x.
4
Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.趋化因子受体CXCR4在胰腺癌中的强烈表达与疾病进展相关。
Oncol Rep. 2006 Dec;16(6):1159-64.
5
Stromal derived factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis.基质衍生因子-1(SDF-1/CXCL12)与CXCR4在肾细胞癌转移中的作用
Mol Cancer. 2006 Nov 3;5:56. doi: 10.1186/1476-4598-5-56.
6
Survey of chemokine receptor expression reveals frequent co-expression of skin-homing CCR4 and CCR10 in adult T-cell leukemia/lymphoma.趋化因子受体表达的调查显示,在成人T细胞白血病/淋巴瘤中,皮肤归巢性CCR4和CCR10经常共同表达。
Leuk Lymphoma. 2006 Oct;47(10):2163-73. doi: 10.1080/10428190600775599.
7
Expression and function of the chemokine receptor CCR7 in thyroid carcinomas.趋化因子受体CCR7在甲状腺癌中的表达及功能
J Endocrinol. 2006 Oct;191(1):229-38. doi: 10.1677/joe.1.06688.
8
The CXCR5 chemokine receptor is expressed by carcinoma cells and promotes growth of colon carcinoma in the liver.CXCR5趋化因子受体由癌细胞表达,并促进结肠癌在肝脏中的生长。
Cancer Res. 2006 Oct 1;66(19):9576-82. doi: 10.1158/0008-5472.CAN-06-1507.
9
Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation.人前列腺LNCaP细胞中CXCL10的过表达激活其受体(CXCR3)的表达并抑制细胞增殖。
Biochim Biophys Acta. 2006 Sep;1762(9):811-8. doi: 10.1016/j.bbadis.2006.06.017. Epub 2006 Jul 25.
10
Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.趋化因子通过激活Raf-1/MEK/ERK和PI3K/Akt/eNOS依赖的信号通路刺激血管生成。
Am J Physiol Heart Circ Physiol. 2006 Dec;291(6):H2836-46. doi: 10.1152/ajpheart.00113.2006. Epub 2006 Jul 28.

趋化因子在肿瘤血管生成和转移中的作用

Chemokines in tumor angiogenesis and metastasis.

作者信息

Singh Seema, Sadanandam Anguraj, Singh Rakesh K

机构信息

Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198-5845, USA.

出版信息

Cancer Metastasis Rev. 2007 Dec;26(3-4):453-67. doi: 10.1007/s10555-007-9068-9.

DOI:10.1007/s10555-007-9068-9
PMID:17828470
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4237067/
Abstract

Chemokines are a large group of low molecular weight cytokines that are known to selectively attract and activate different cell types. Although the primary function of chemokines is well recognized as leukocyte attractants, recent evidences indicate that they also play a role in number of tumor-related processes, such as growth, angiogenesis and metastasis. Chemokines activate cells through cell surface seven trans-membranes, G-protein-coupled receptors (GPCR). The role played by chemokines and their receptors in tumor pathophysiology is complex as some chemokines favor tumor growth and metastasis, while others may enhance anti-tumor immunity. These diverse functions of chemokines establish them as key mediators between the tumor cells and their microenvironment and play critical role in tumor progression and metastasis. In this review, we present some of the recent advances in chemokine research with special emphasis on its role in tumor angiogenesis and metastasis.

摘要

趋化因子是一大类低分子量细胞因子,已知其能选择性地吸引和激活不同的细胞类型。尽管趋化因子的主要功能被公认为白细胞吸引剂,但最近的证据表明,它们也在许多与肿瘤相关的过程中发挥作用,如生长、血管生成和转移。趋化因子通过细胞表面的七次跨膜G蛋白偶联受体(GPCR)激活细胞。趋化因子及其受体在肿瘤病理生理学中所起的作用很复杂,因为一些趋化因子促进肿瘤生长和转移,而另一些可能增强抗肿瘤免疫力。趋化因子的这些多样功能使其成为肿瘤细胞与其微环境之间的关键介质,并在肿瘤进展和转移中起关键作用。在本综述中,我们介绍了趋化因子研究的一些最新进展,特别强调其在肿瘤血管生成和转移中的作用。